Made O'Meter
Discover where a brand or product originates
RINVOQ
rinvoq.comownerAbbVie Inc. (USA)
originUnited States
RINVOQ pertenece a AbbVie Inc., con sede en Estados Unidos. Sí. El propietario último de RINVOQ, AbbVie Inc., tiene su sede en Estados Unidos.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical diseases.
AbbVie Deutschland GmbH & Co. KG
Productos de RINVOQ (2)
- RINVOQ 30 mg upadacitinib · Pharmaceutical – Immunomodulator
- RINVOQ 15 mg Upadacitinib · Other – Pharmaceutical (JAK inhibitor)
Alternativas a RINVOQ
- Teva · Teva Pharmaceutical Industries Ltd. (Israel)
- Sandoz · Sandoz Group AG (Suiza)
- Cinfa · Infarco, S.A. (España)
- Ratiopharm · Teva Pharmaceutical Industries Ltd. (Israel)
- HEXAL · Sandoz Group AG (Suiza)
- EG (EuroGenerici) · STADA Arzneimittel AG (Alemania)
Fuentes: abbvie.com, rinvoq.com
Verificar otro productodisclaimer
poweredBy